Whitepaper
A Brief Introduction to Amorphous Solid Dispersion Technology
05 Dec 2023
en
Amorphous solid dispersions are a proven technology to drastically alter API properties, specifically overcoming poor solubility, slow dissolution, and low bioavailability.
Identifying the ideal ASD formulation to provide sufficient solubility and the targeted drug release rate.
Generating milligram quantities for early-stage screening up to kilogram-scale for clinical studies and marketed products.
Utilizing ASD in simple early-stage suspensions or formulating into final drug product tablets and capsules.
Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.
Our capabilities span three specialized platforms:
Small Molecule
Crystal Bio Solutions
Crystal NAX
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.
Subscribe to be the first to get the updates!